MYCN and neuroblastoma: Downregulating MYCN in the MYCN-amplified IMR5/75 neuroblastoma cell model15 (approximately 65% reduction; Fig. 1a) slowed cell proliferation without inducing cell death (Extended Data Fig. 1a,b) and reduced the intracellular pools of all amino acids (Fig. 1b).